NICE Issues First Rapid Appraisal Draft Guidance On Docetaxel And Paclitaxel For The Treatment Of Early Breast Cancer, UK

... The National Institute for Health and Clinical Excellence (NICE) has today issued its first draft guidance through its new rapid appraisal process. Draft guidance on the clinical and cost-effectiveness of docetaxel and paclitaxel for the treatment of early breast cancer following surgery is now available for comment... click link for more info. ...